S. 1101 · 108th Congress
National Cancer Act of 2003
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 108th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
D
FeinsteinSponsor25 cosponsors · 20 D, 4 R, 1 I
D
Boxer
MC
D
Cantwell
SC
R
Collins
HC
D
Clinton
JC
D
Corzine
TD
D
Daschle
CD
D
Dodd
FH
D
Hollings
KH
R
Hutchison
JJ
I
Jeffords
TJ
D
Johnson
TK
D
Kennedy
JK
D
Kerry
BL
D
Lincoln
FL
D
Lautenberg
PL
D
Leahy
ML
D
Landrieu
BM
D
Mikulski
PM
D
Murray
BN
D
Nelson
JR
D
Reed
CS
D
Schumer
DS
D
Stabenow
GS
R
Smith
OS
R
Snowe24 signed on when it was introduced; the rest joined later. Cosponsors who withdrew aren't shown.
National Cancer Act of 2003 - Provides a comprehensive Federal effort relating to treatments for and the prevention of cancer.
What it does: CRS summary · Introduced in Senate · May 21, 2003
Amends the Public Health Service Act to fund prevention, detection, and treatment programs of the National Cancer Institute, including translational cancer research (research needed to transform scientific discoveries into approaches and products to treat and cure cancer). Directs the Secretary of Health and Human Services to carry out a research grant program to fund projects that seek to develop cancer treatments that target cancer cells.
Addresses issues of cancer care, including: (1) clinical trial participation; (2) workforce needs; (3) cancer survivorship; (4) cancer care guidelines; (5) the supply of researchers; (6) a colorectal cancer screening demonstration program; and (7) an Institute of Medicine study on whether to provide medical coverage under title XVIII (Medicare) of the Social Security Act to certain cancer patients.
Directs the Commissioner of Food and Drugs to submit to Congress a plan outlining steps to accelerate the process for reviewing and approving new cancer drugs and treatments.
Requires health insurance plans covered by the Public Health Service Act and the Employee Retirement Income Security Act of 1974 to provide: (1) coverage for clinical trials; (2) coverage of cancer screening, including tobacco and nutrition counseling and genetic testing; and (3) patient access to benefit information.
Addresses issues of managing physicians and quality of care for cancer patients covered by such plans, including designating a lead managing physician.
Amends the Public Health Service Act to authorize the Secretary of Health and Human Services, acting through the Administrator of the Health Resources and Services Administration, to make grants for: (1) model programs to provide services for cancer and chronic diseases to individuals of health disparity populations; and (2) patient navigators for managing such care of such individuals.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: National Cancer Act of 2003
Latest action (May 21, 2003): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: May 21, 2003
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.